Treatment of Melasma With Oral Administration of Tranexamic Acid.
Summary of "Treatment of Melasma With Oral Administration of Tranexamic Acid."
Melasma is a common pigmentary disorder among Asian women. The available therapies such as bleaching agents, chemical peeling, laser, and intense pulsed light are not satisfactory or safe. In the search to find a new treatment therapy for melasma, oral administration of tranexamic acid (TA) was studied clinically in Chinese patients.
The study enrolled 74 patients. Tranexamic acid tablets were prescribed at a dosage of 250 mg twice daily for a therapeutic period of 6 months. All the patients were followed up for more than 6 months after the treatment. The effects of treatment were evaluated by two physicians independently and by the patient based on improvement of pigmentation and reduction in melasma size. These were graded into four levels: excellent, good, fair, and poor.
After 6 months of treatment, the effects were graded as follows: excellent (10.8 %, 8/74), good (54 %, 40/74), fair (31.1 %, 23/74), and poor (4.1 %, 3/74). Side effects of TA such as gastrointestinal discomfort (5.4 %) and hypomenorrhea (8.1 %) were observed, but no severe complications were found. The recurrence of melasma was observed in seven cases (9.5 %).
Oral administration of TA is an effective and safe therapy for the treatment of melasma. LEVEL OF EVIDENCE
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors at www.springer.com/00266.
Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People's Hospital, #158 Shangtang Road, Hangzhou, 310014, People's Republic of China, email@example.com.
This article was published in the following journal.
Name: Aesthetic plastic surgery
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22552446
- DOI: http://dx.doi.org/10.1007/s00266-012-9899-9
Medical and Biotech [MESH] Definitions
Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.
Antifibrinolytic hemostatic used in severe hemorrhage.
A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.
This article reviews an old drug tranexamic acid to its new use in the treatment of melasma. Its mechanism of preventing the activation of melanocyte from UV light, hormone and injured kerationcyte th...
Abstract Background: Recently, tranexamic acid (TNA) containing oral medication has gained public attention, claiming for whitening effects. Objective: This study was performed to evaluate the clinic...
Bleeding is a main complication in ENT surgery especially in oral and nasal interventions. Based on good results in local application of tranexamic acid after dental extraction, the different possibil...
Aim: To evaluate the efficacy and safety of oral, modified-release tranexamic acid in women with heavy menstrual bleeding and fibroids. Materials & methods: This was a pooled analysis of two pivotal P...
Cases description This is a retrospective study, based on analysis of data from patients with previous adverse drug reactions admitted to the Allergy and Clinical Immunology Division of both the Unive...
This prospective randomized double-blind placebo vs control study aims at verifying the efficacy of tranexamic acid administration in reducing perioperative bleeding in patients undergoing...
Tranexamic acid is administered intravenously to prevent bleeding associated with cardiac surgery and cardiopulmonary bypass. We have developed an assay for tranexamic acid. We have deve...
Investigation of tranexamic acid (TXA) for reducing perioperative blood loss and transfusion requirement in pediatric patients with secondary scoliosis undergoing posterior spinal fusion.
The purpose of this prospective, randomized, controlled, single-blinded investigation is to study the efficacy, tolerability and safety of azelaic acid iontophoresis (AAI) versus topical t...
The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.